A case study applying a novel approach to estimate the social impact of a medical innovation - The use of secukinumab for psoriatic arthritis in Germany.
Conclusions: The improvements in PsA related functional impairment could lead to sizable productivity effects within the economy.
PMID: 31322444 [PubMed - as supplied by publisher]
Source: Expert Review of Pharmacoeconomics and Outcomes Research - Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research
More News: Arthritis | Economy | Germany Health | Health Management | Psoriatic Arthritis | Rheumatology | Study